DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design

2026-04-15 · Source: Machine learning : nature.com subject feeds · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Mathematics & Computational Sciences · Depth: Expert, long

Summary

DualGPT-AB, a new dual-stage conditional generative pre-trained transformer (GPT) framework, has been developed for therapeutic antibody design, addressing the challenge of simultaneously optimizing multiple properties like antigen-binding specificity, viscosity, clearance, and immunogenicity. Published on April 15, 2026, this framework uses a conditional GPT to model sequence-property relationships by representing desired properties as learnable embeddings. It also integrates a reinforcement learning strategy to enhance antibody sequence exploration and optimization efficiency. Computational experiments demonstrated DualGPT-AB's ability to generate antibody heavy chain complementarity-determining region 3 (CDRH3) sequences that meet multiple desired properties. Notably, 8 out of 100 randomly selected antibodies from the designed library showed excellent HER2-binding affinities. Wet-laboratory validation confirmed that DualGPT-AB identifies antibodies with enhanced tumoricidal activity compared to Herceptin, a standard drug for HER2-positive cancers.

Key takeaway

For AI Scientists and Machine Learning Engineers focused on biopharmaceutical development, DualGPT-AB offers a promising approach to accelerate therapeutic antibody design. You should explore this dual-stage generative optimization framework to efficiently balance multiple antibody properties, potentially reducing the time and resources typically required for drug discovery. Consider integrating similar conditional GPT and reinforcement learning strategies into your own antibody design pipelines to improve optimization efficiency and discover novel candidates with enhanced therapeutic efficacy.

Key insights

DualGPT-AB optimizes therapeutic antibody design by combining conditional GPT with reinforcement learning for multi-property sequence generation.

Principles

• Represent desired properties as learnable embeddings.
• Integrate reinforcement learning for sequence exploration.

Method

DualGPT-AB employs a dual-stage process: a conditional GPT models sequence-property relationships via learnable embeddings, followed by a reinforcement learning strategy to promote antibody sequence exploration and improve optimization efficiency.

In practice

• Generate CDRH3 sequences with multiple desired properties.
• Design antibodies with enhanced tumoricidal activity.

Topics

• DualGPT-AB
• Therapeutic Antibody Design
• Generative AI
• Reinforcement Learning
• HER2-binding Affinity

Code references

• 23AIBox/DualGPT-AB

Best for: AI Scientist, Machine Learning Engineer, Research Scientist

Related on AIssential

• Enhancing success rates in therapeutic antibody design through generative models — DualGPT-AB is a dual-stage GPT framework optimizing therapeutic antibody design for specificity and developability.
• AgForce Enables Antigen-conditioned Generative Antibody Design — Existing antibody design models fail to condition on antigen, suffering from antigen blindness and vocabulary collapse due to cross-entropy loss.
• An Evolutionary Approach for Designing Stable and Highly Expressible Low-Immunogenicity Therapeutic mRNA Sequences — The BERT-GA framework optimizes therapeutic mRNA sequences for balanced translation efficiency, structural stability, and low immunogenicity.
• Bridging the phenotype-target gap for molecular generation via multi-objective reinforcement learning — ExMolRL combines phenotype-guided generation with target-aware reinforcement learning for de novo drug discovery.
• Scaling antibody language models improves structure aware representation for antibody engineering — Scaling antibody language models with advanced tokenization improves structure-aware representation for engineering.
• Generalizable mutation-effect prediction across adaptive immune recognition via unified multimodal framework — UniAIR unifies multimodal data and structural information to predict immune mutation effects with high generalizability.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.